K KemPharm Inc
K
Closed
0
Overview
Share price change
24h
Min
Max
Income | 24M 36M |
|---|---|
Sales | 2.1M 36M |
P/E Sector Avg | 6.736 56.269 |
EPS | 0.6 |
Profit margin | 100.268 |
Employees | 61 |
EBITDA | 28M 43M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +102.07% upside |
Next Earnings | 11 Aug 2026 |
|---|
Market Cap | 234M 828M |
|---|---|
Previous open | 0 |
Previous close | 0 |
KemPharm Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
KemPharm Inc Forecast
Price Target
By TipRanks
102.07% upside
12 Months Forecast
Average 28.25 USD 102.07%
High 35 USD
Low 21 USD
Based on 9 Wall Street analysts offering 12 month price targets forKemPharm Inc - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$